menu
    • menu

    Find Hydrocortisone Butyrate manufacturers, exporters & distributors on PharmaCompass

    EUROAPI Hydrocortisone

    Virtual Booth

    Contact Supplier

    Hydrocortisone Butyrate

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    Pfizer Centreone Hydrocortisone Butyrate

    Virtual Booth

    Contact Supplier

    Symbiotech Hydrocortisone

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    15

    API Suppliers

    API Suppliers

    7

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    3

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    5

    NDC API

    NDC API

    0

    VMF

    NDC API

    9

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 8,095

    MARKET PLACE

    2

    API

    1

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    35

    FDF Dossiers

    FDF Dossiers

    16

    FDA Orange Book

    FDA (Orange Book)

    9

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    5

    South Africa

    South Africa

    5

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF DossiersDRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    1

    Others

    PATENTS & EXCLUSIVITIES

    1

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    4

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    4,682,949

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    66 RELATED EXCIPIENT COMPANIES

    119EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Hydrocortisone 17-butyrate, Cortisol 17-butyrate, Hydrocortisone-17-butyrate, 13609-67-1, Locoid, Hydrocortisone-17alpha-butyrate
    Molecular Formula
    C25H36O6
    Molecular Weight
    432.5  g/mol
    InChI Key
    BMCQMVFGOVHVNG-TUFAYURCSA-N
    FDA UNII
    05RMF7YPWN
    Hydrocortisone Butyrate
    Hydrocortisone Butyrate is the butyrate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2. Lack of phospholipase A2 prevents the release of arachidonic acid, precursor for inflammatory mediator prostaglandins and leukotrienes, from the cell membrane. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leading to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.
    1 2D Structure

    Hydrocortisone Butyrate

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate
    2.1.2 InChI
    InChI=1S/C25H36O6/c1-4-5-21(30)31-25(20(29)14-26)11-9-18-17-7-6-15-12-16(27)8-10-23(15,2)22(17)19(28)13-24(18,25)3/h12,17-19,22,26,28H,4-11,13-14H2,1-3H3/t17-,18-,19-,22+,23-,24-,25-/m0/s1
    2.1.3 InChI Key
    BMCQMVFGOVHVNG-TUFAYURCSA-N
    2.1.4 Canonical SMILES
    CCCC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)CCC34C)O)C)C(=O)CO
    2.1.5 Isomeric SMILES
    CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)C(=O)CO
    2.2 Other Identifiers
    2.2.1 UNII
    05RMF7YPWN
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Cortisol 17-butyrate

    2. Hydrocortisone 17-butyrate

    3. Hydrocortisone-17-butyrate

    4. Locoid

    2.3.2 Depositor-Supplied Synonyms

    1. Hydrocortisone 17-butyrate

    2. Cortisol 17-butyrate

    3. Hydrocortisone-17-butyrate

    4. 13609-67-1

    5. Locoid

    6. Hydrocortisone-17alpha-butyrate

    7. 17-o-butyrylcortisol

    8. 11beta,17,21-trihydroxypregn-4-ene-3,20-dione 17-butyrate

    9. H-17-b

    10. Chebi:31674

    11. 05rmf7ypwn

    12. Mls000028716

    13. Mls001076086

    14. Laticort

    15. Nsc-758433

    16. Alfason

    17. Hycortate

    18. Lacoidon

    19. Smr000058859

    20. Bucort

    21. Lacoid

    22. Dsstox_cid_25896

    23. Dsstox_rid_81208

    24. Dsstox_gsid_45896

    25. 11beta,21-dihydroxy-3,20-dioxopregn-4-en-17-yl Butanoate

    26. 11beta,21-dihydroxy-17alpha-butyryloxy-4-pregnene-3,20-dione

    27. Hb(sub 17)

    28. Cas-13609-67-1

    29. Cortisol, 17-butyrate

    30. H.17b

    31. [(8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Butanoate

    32. Einecs 237-093-4

    33. Unii-05rmf7ypwn

    34. Ncgc00095037-01

    35. Locoid (tn)

    36. Hydrocortisone-butyrate

    37. Opera_id_188

    38. Hydrocortisone Butyrate [usan:usp:ban:jan]

    39. Butyric Acid Hydrocortisone

    40. Epitope Id:119710

    41. 11-beta,17-alpha,21-trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate

    42. Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11-beta)-

    43. Schembl4695

    44. Chembl1683

    45. Mls002207122

    46. Dtxsid4045896

    47. Bdbm323672

    48. Hms2231b16

    49. Bcp11925

    50. Hy-b0983

    51. Zinc3977794

    52. Tox21_111397

    53. Ac-492

    54. Hydrocortisone Butyrate (jp17/usp)

    55. Hydrocortisone Butyrate [jan]

    56. S6590

    57. Hydrocortisone Butyrate [usan]

    58. Akos015895443

    59. Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11.beta.)-

    60. Pregn-4-ene-3,20-dione, 11,21-dihydroxy-17-(1-oxobutoxy)-, (11beta)-

    61. Tox21_111397_1

    62. Cs-4474

    63. Db14540

    64. Hydrocortisone Butyrate [mart.]

    65. Hydrocortisone Butyrate [vandf]

    66. Nsc 758433

    67. Hydrocortisone Butyrate [usp-rs]

    68. Hydrocortisone Butyrate [who-dd]

    69. Hydrocortisone 17-butyrate [mi]

    70. Ncgc00274077-01

    71. Us10188667, Example 00013

    72. Us10188667, Example 00024

    73. (1s,10s,11s,15s,17s,2r,14r)-17-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-5-ox Otetracyclo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl Butanoate

    74. H1506

    75. Hydrocortisone Butyrate [orange Book]

    76. D01619

    77. Hydrocortisone Butyrate [usp Monograph]

    78. 609h671

    79. A807026

    80. Q5954743

    81. W-108252

    82. Hydrocortisone 17-butyrate 100 Microg/ml In Methanol

    83. Hydrocortisone Butyrate (hydrocortisone 17-butyrate)

    84. 11.beta.,17,21-trihydroxypregn-4-ene-3,20-dione 17-butyrate

    85. Hydrocortisone Butyrate, United States Pharmacopeia (usp) Reference Standard

    86. (8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl Butanoate

    87. [(8s,9s,10r,11s,13s,14s,17r)-10,13-dimethyl-11-oxidanyl-17-(2-oxidanylethanoyl)-3-oxidanylidene-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Butanoate

    88. Butanoic Acid [(8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxy-1-oxoethyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Ester

    2.3.3 Other Synonyms

    1. Hydrocortisone Butyrate Propionate

    2. Hydrocortisone Buteprate

    3.  Hydrocortisone Probutate

    4. Pandel

    2.4 Create Date
    2005-06-24
    3 Chemical and Physical Properties
    Molecular Weight 432.5 g/mol
    Molecular Formula C25H36O6
    XLogP33.2
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count6
    Exact Mass432.25118886 g/mol
    Monoisotopic Mass432.25118886 g/mol
    Topological Polar Surface Area101 Ų
    Heavy Atom Count31
    Formal Charge0
    Complexity817
    Isotope Atom Count0
    Defined Atom Stereocenter Count7
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 3  
    Drug NameLOCOID
    Active IngredientHYDROCORTISONE BUTYRATE
    CompanyPRECISION DERMAT (Application Number: N018514); PRECISION DERMAT (Application Number: N018652); PRECISION DERMAT (Application Number: N019116); PRECISION DERMAT (Application Number: N022076. Patents: 7378405, 7981877)

    2 of 3  
    Drug NameHYDROCORTISONE BUTYRATE
    Active IngredientHYDROCORTISONE BUTYRATE
    CompanyACTAVIS MID ATLANTIC (Application Number: A205134); GLENMARK GENERICS (Application Number: A202145); TARO PHARM INDS (Application Number: A076364); TARO PHARM INDS (Application Number: A076654); TARO (Application Number: A076842); TELIGENT PHARMA INC (Application Number: A209556)

    3 of 3  
    Drug NameLOCOID LIPOCREAM
    Active IngredientHYDROCORTISONE BUTYRATE
    CompanyPRECISION DERMAT (Application Number: N020769)

    4.2 Drug Indication

    For the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Also used to treat endocrine (hormonal) disorders (adrenal insufficiency, Addisons disease). It is also used to treat many immune and allergic disorders, such as arthritis, lupus, severe psoriasis, severe asthma, ulcerative colitis, and Crohn's disease.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Hydrocortisone is the most important human glucocorticoid. It is essential for life and regulates or supports a variety of important cardiovascular, metabolic, immunologic and homeostatic functions. Topical hydrocortisone is used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids and sex steroids by having different receptors, target cells, and effects. Technically, the term corticosteroid refers to both glucocorticoids and mineralocorticoids, but is often used as a synonym for glucocorticoid. Glucocorticoids suppress cell-mediated immunity. They act by inhibiting genes that code for the cytokines IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-8 and TNF-alpha, the most important of which is the IL-2. Reduced cytokine production limits T cell proliferation. Glucocorticoids also suppress humoral immunity, causing B cells to express lower amounts of IL-2 and IL-2 receptors. This diminishes both B cell clonal expansion and antibody synthesis. The diminished amounts of IL-2 also leads to fewer T lymphocyte cells being activated.

    5.2 MeSH Pharmacological Classification

    Dermatologic Agents

    Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)

    5.3 FDA Pharmacological Classification
    5.3.1 Pharmacological Classes
    Corticosteroid [EPC]; Corticosteroid Hormone Receptor Agonists [MoA]
    5.4 ATC Code

    D - Dermatologicals

    D07 - Corticosteroids, dermatological preparations

    D07A - Corticosteroids, plain

    D07AB - Corticosteroids, moderately potent (group ii)

    D07AB02 - Hydrocortisone butyrate

    5.5 Absorption, Distribution and Excretion

    Absorption

    Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption.

    Route of Elimination

    Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.

    5.6 Metabolism/Metabolites

    Primarily hepatic via CYP3A4

    5.7 Biological Half-Life

    6-8 hours

    5.8 Mechanism of Action

    Hydrocortisone binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. Specifically glucocorticoids induce lipocortin-1 (annexin-1) synthesis, which then binds to cell membranes preventing the phospholipase A2 from coming into contact with its substrate arachidonic acid. This leads to diminished eicosanoid production. The cyclooxygenase (both COX-1 and COX-2) expression is also suppressed, potentiating the effect. In other words, the two main products in inflammation Prostaglandins and Leukotrienes are inhibited by the action of Glucocorticoids. Glucocorticoids also stimulate the lipocortin-1 escaping to the extracellular space, where it binds to the leukocyte membrane receptors and inhibits various inflammatory events: epithelial adhesion, emigration, chemotaxis, phagocytosis, respiratory burst and the release of various inflammatory mediators (lysosomal enzymes, cytokines, tissue plasminogen activator, chemokines etc.) from neutrophils, macrophages and mastocytes. Additionally the immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649183400,"product":"HYDROCORTISONE BUTYRATE USP (MICRONIZED)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"CURIA","supplierCountry":"SPAIN","foreign_port":"N\/A","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"8000","totalValueFC":"8153.9","currency":"USD","unitRateINR":"615200","date":"06-Apr-2022","totalValueINR":"615200","totalValueInUsd":"8153.9","indian_port":"Indore-EPZ\/SEZ","hs_no":"29372900","bill_no":"1002260","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Micronized","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665945000,"product":"HYDROCORTISONE BUTYRATE USP 2022 MICRONIZED","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"CURLA SPAIN S.A.U","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"8004.1","totalValueFC":"8020.2","currency":"USD","unitRateINR":"659936","date":"17-Oct-2022","totalValueINR":"659936","totalValueInUsd":"8020.2","indian_port":"Indore-EPZ\/SEZ","hs_no":"29372900","bill_no":"1006937","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Micronized","supplierPort":"BARCELONA","supplierAddress":"N\/A","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715625000,"product":"HYDROCORTISONE BUTYRATE USP (MICRONIZED) (CAS NO. 13609-67-1)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"CURIA","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"8004.1","totalValueFC":"8099.7","currency":"USD","unitRateINR":"675144","date":"14-May-2024","totalValueINR":"675144","totalValueInUsd":"8099.7","indian_port":"Indore-EPZ\/SEZ","hs_no":"29372900","bill_no":"1003380","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Micronized","supplierPort":"BARCELONA","supplierAddress":"N\/A","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721759400,"product":"HYDROCORTISONE BUTYRATE USP (MICRONIZED)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"CURIA","supplierCountry":"SPAIN","foreign_port":"MADRID","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"8004.1","totalValueFC":"16191.8","currency":"USD","unitRateINR":"676745","date":"24-Jul-2024","totalValueINR":"1353490","totalValueInUsd":"16191.8","indian_port":"Indore-EPZ\/SEZ","hs_no":"29372900","bill_no":"1005417","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Micronized","supplierPort":"MADRID","supplierAddress":"N\/A","customerAddress":"159, C.S.T. ROAD,"}]
    06-Apr-2022
    24-Jul-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    DRUG PRODUCT COMPOSITIONS

    Do you need Business Intel? Ask us

    DOSAGE - CREAM;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 18514

    read-more

    DOSAGE - OINTMENT;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 18652

    read-more

    DOSAGE - SOLUTION;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 19116

    read-more

    DOSAGE - CREAM;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 20453

    read-more

    DOSAGE - CREAM;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 20769

    read-more

    DOSAGE - LOTION;TOPICAL - 0.1%

    USFDA APPLICATION NUMBER - 22076

    read-more

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Topical

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Fillers, Diluents & Binders

    read-more
    read-more

    Granulation

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Hydrocortisone Butyrate Manufacturers

    A Hydrocortisone Butyrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydrocortisone Butyrate, including repackagers and relabelers. The FDA regulates Hydrocortisone Butyrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydrocortisone Butyrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Hydrocortisone Butyrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Hydrocortisone Butyrate Suppliers

    A Hydrocortisone Butyrate supplier is an individual or a company that provides Hydrocortisone Butyrate active pharmaceutical ingredient (API) or Hydrocortisone Butyrate finished formulations upon request. The Hydrocortisone Butyrate suppliers may include Hydrocortisone Butyrate API manufacturers, exporters, distributors and traders.

    click here to find a list of Hydrocortisone Butyrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Hydrocortisone Butyrate USDMF

    A Hydrocortisone Butyrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Hydrocortisone Butyrate active pharmaceutical ingredient (API) in detail. Different forms of Hydrocortisone Butyrate DMFs exist exist since differing nations have different regulations, such as Hydrocortisone Butyrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Hydrocortisone Butyrate DMF submitted to regulatory agencies in the US is known as a USDMF. Hydrocortisone Butyrate USDMF includes data on Hydrocortisone Butyrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hydrocortisone Butyrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Hydrocortisone Butyrate suppliers with USDMF on PharmaCompass.

    Hydrocortisone Butyrate JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The Hydrocortisone Butyrate Drug Master File in Japan (Hydrocortisone Butyrate JDMF) empowers Hydrocortisone Butyrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the Hydrocortisone Butyrate JDMF during the approval evaluation for pharmaceutical products. At the time of Hydrocortisone Butyrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of Hydrocortisone Butyrate suppliers with JDMF on PharmaCompass.

    Hydrocortisone Butyrate NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydrocortisone Butyrate as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Hydrocortisone Butyrate API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Hydrocortisone Butyrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Hydrocortisone Butyrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydrocortisone Butyrate NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Hydrocortisone Butyrate suppliers with NDC on PharmaCompass.

    Hydrocortisone Butyrate GMP

    Hydrocortisone Butyrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Hydrocortisone Butyrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydrocortisone Butyrate GMP manufacturer or Hydrocortisone Butyrate GMP API supplier for your needs.

    Hydrocortisone Butyrate CoA

    A Hydrocortisone Butyrate CoA (Certificate of Analysis) is a formal document that attests to Hydrocortisone Butyrate's compliance with Hydrocortisone Butyrate specifications and serves as a tool for batch-level quality control.

    Hydrocortisone Butyrate CoA mostly includes findings from lab analyses of a specific batch. For each Hydrocortisone Butyrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Hydrocortisone Butyrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydrocortisone Butyrate EP), Hydrocortisone Butyrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydrocortisone Butyrate USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search